ARVN Q2 2020 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+43.1% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$26M-460.8% margin

Net Income

-$25M-438.9% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

-7.9%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$23M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$263M

Total Liabilities

$65M

Stockholders' Equity

$198M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+43.1%
Gross Profit	$6M	$4M	+43.1%
Operating Income	-$26M	-$18M	-43.7%
Net Income	-$25M	-$17M	-47.0%